Pacific Biosciences of California Inc [PACB] stock is trading at $1.54, down -6.10%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PACB shares have gain 4.05% over the last week, with a monthly amount drifted -14.92%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pacific Biosciences of California Inc [NASDAQ: PACB] stock has seen the most recent analyst activity on November 11, 2024, when UBS downgraded its rating to a Neutral. On April 22, 2024, downgrade downgraded it’s rating to Neutral. Goldman downgraded its rating to a Neutral and decreased its price target to $2.50 on April 18, 2024. Stephens initiated its recommendation with a Overweight and recommended $11 as its price target on December 14, 2023. In a note dated December 13, 2023, Wolfe Research initiated an Peer Perform rating.
Pacific Biosciences of California Inc [PACB] stock has fluctuated between $1.16 and $6.09 over the past year. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Pacific Biosciences of California Inc [NASDAQ: PACB] shares were valued at $1.54 at the most recent close of the market. An investor can expect a potential return of 94.81% based on the average PACB price forecast.
Analyzing the PACB fundamentals
Pacific Biosciences of California Inc [NASDAQ:PACB] reported sales of 154.01M for the trailing twelve months, which represents a drop of -32.79%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at -2.66%, Pretax Profit Margin comes in at -2.0%, and Net Profit Margin reading is -2.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.24, Equity is -0.57 and Total Capital is -0.33. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4833 points at the first support level, and at 1.4267 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6433, and for the 2nd resistance point, it is at 1.7467.
Ratios To Look Out For
For context, Pacific Biosciences of California Inc’s Current Ratio is 12.63. In addition, the Quick Ratio stands at 11.13 and the Cash Ratio stands at 10.73. Considering the valuation of this stock, the price to sales ratio is 2.74, the price to book ratio is 0.93.
Transactions by insiders
Recent insider trading involved Farmer Michele, that happened on Feb 18 ’25 when 24349.0 shares were sold. Van Oene Mark completed a deal on Feb 18 ’25 to sell 0.1 million shares. Meanwhile, HENRY CHRISTIAN O sold 0.26 million shares on Feb 18 ’25.
